Brief: Vivani Medical Achieves First Implant And Full Enrollment In The First-In-Human Clinical Trial Of GLP-1 Implant NPM-115 In Obese Or Overweight Adults
13/03/2025 11:31
March 13 (Reuters) - Vivani Medical Inc VANI.O: VIVANI MEDICAL ACHIEVES FIRST IMPLANT AND FULL ENROLLMENT IN THE FIRST-IN-HUMAN CLINICAL TRIAL OF GLP-1 IMPLANT NPM-115 IN OBESE OR OVERWEIGHT ADULTS VIVANI MEDICAL INC: NPM-115 HAS SHOWED COMPARABLE PRECLINICAL WEIGHT LOSS TO INJECTIONS OF SEMAGLUTIDE VIVANI MEDICAL INC - TOP-LINE STUDY RESULTS EXPECTED IN MID-2025 Source text: ID:nBw3vY73Xa Further company coverage: VANI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivani Medical
See all newsVivani Medical Q2 net loss narrows as expenses fall
Vivani Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Vivani Medical Inc expected to post a loss of 8 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Vera Therapeutics, Vera Therapeutics, Nvidia
U.S. STOCKS ON THE MOVE-Revolution Medicines, Vivani Medical, Nvidia